Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 

Allergopharma – allergen immunotherapy

Allergopharma, our global Allergy business, develops, produces and markets diagnostics and prescription drugs for causal therapy of type 1 allergies.

Diagnostics

A precise diagnosis is a prerequisite for effective therapy. Allergopharma offers a wide range of prick and provocation test solutions to identify the specific substances that trigger allergic reactions.

Therapy

Allergen immunotherapy is the only causal therapy for treating allergies to unavoidable allergens. The company offers a wide range of therapeutic drugs for subcutaneous immunotherapy (SCIT); Allergopharma is the global market leader for allergoids (modified allergens). Allergoids enable fast, safe application at a high dosis, which is crucial for therapeutic success.

Avoiding contact with allergens

Allergopharma offers the ALLERGOCOVER® over-the-counter intermediate covers for people with an allergy to mites. By encasing mattresses, comforters and pillows in the special covers, contact with the allergy triggers – mites and their feces – is stopped.

 

Allergopharma – Allergen immunotherapy

Allergopharma is one of the leading manufacturers of diagnostics and prescription drugs for allergen immunotherapy (AIT) AIT (hyposensitization, desensitization, allergy immunization) is the only causal therapy for treating allergies to unavoidable allergens. AIT is primarily carried out by physicians who specialize in allergies, such as ENT doctors, dermatologists, pediatricians and pulmonologists.
With its own research department and in cooperation with research institutes and other partners, the company is helping develop a better understanding of the immunological mechanism that underlies the development of allergies and is actively working on the next generation of drugs for allergen immunotherapy. 

Allergopharma portfolio
Diagnostics

Prick test solutions  
Provocation test solutions  

Basic diagnostics

TherapyAllergovit® (pollen preparation)  
Acaroid® (mite preparation)  
Novo Helisen® Depot  
Basic therapeutics
Avoiding contact with allergensAllergocover®

More in M – The Explorer Magazine:

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

ALLERGOPHARMA

Allergopharma

M - THE EXPLORER MAGAZINE

M - The Explorer Magazine